agalsidase alfa
SpainDrugs containing this active substance
-
It is used for the long-term treatment of adult, adolescent, and pediatric patients aged 7 years and older with a confirmed diagnosis of Fabry disease.
Form: solution for infusion, concentrate
Active substance Dosage agalsidase alfa 1 mg Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch